EXOZYMES INC. (EXOZ) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US4618741098

Price
4.11 USD
Market cap
38.15 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

EXOZYMES INC. financials

Fiscal year2025
Operating income-9.72 m USD
EBIT-9.26 m USD
Net income-9.16 m USD
Diluted EPS – continuing operations-1.09 USD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About EXOZYMES INC.

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.